Quantitative fdg pet assessment for oncology therapy

Abstract

Positron emission tomography (PET) has unique characteristics for quantitative assessment of tumour biology in vivo. Accumulation of F‐18 fluorodeoxyglucose (FDG) may reflect tu-mour characteristics based on its metabolic activity. Quantitative assessment of FDG uptake can often be applied for treatment monitoring after chemotherapy or chemoradiotherapy. Numerous studies indicated biochemical change assessed by FDG PET as a more sensitive marker than mor-phological change estimated by CT or MRI. In addition, those with complete metabolic response after therapy may show better disease‐free survival and overall survival than those with other re-sponses. Assessment of metabolic change may be performed using absolute FDG uptake in the tu-mour (standardized uptake value: SUV). In addition, volumetric parameters such as metabolic tu-mour volume (MTV) have been introduced for quantitative assessment of FDG uptake in tumour. More recently, radiomics approaches that focus on image‐based precision medicine have been applied to FDG PET, as well as other radiological imaging. Among these, texture analysis extracts intratumoral heterogeneity on a voxel‐by‐voxel basis. Combined with various machine learning techniques, these new quantitative parameters hold a promise for assessing tissue characterization and predicting treatment effect, and could also be used for future prognosis of various tumours, although multicentre clinical trials are needed before application in clinical settings.